You Position: Home > Paper

The state of diagnosis and treatment of patients with primary myelofibrosis

( views:736, downloads:614 )
Author:
No author available
Journal Title:
JOURNAL OF LEUKEMIA & LYMPHOMA
Issue:
9
DOI:
10.3760/cma.j.issn.1009-9921.2010.09.001
Key Word:
原发性骨髓纤维化;诊断;治疗;预后;Primary myelofibrosis;Diagnosis;Treatment;Prognosis

Abstract: During the past few years, European consensus on grading bone marrow fibrosis, the Dynamic International Prognostic Scoring System (DIPSS) for primary myelofibrosis(PMF) and response criteria for PMF were developed, and some new drugs, such as the immunomodulator drugs (IMiDs) and JAK2 inhibitor are available for PMF. The recent advances were summarized and future issues were discussed.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn